CVS Health Corp

Research CVS Health Corp (CVS) on Bullrun: valuation model: 27.9% overvalued, market cap USD 132.16B, P/E 45.5, dividend yield 2.6%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCVS
• ExchangeNYSE
• CountryUnited States
• SectorHealthcare
• IndustryHealthcare Plans
• CurrencyUSD
• Valuation signal27.9% overvalued
• Market capUSD 132.16B
• P/E45.5
• Dividend yield2.6%
• Financial periodFY2025
• RevenueUSD 402.07B
• Revenue growth7.8%
• Net incomeUSD 1.77B
• Free cash flowUSD 7.81B
• Gross margin45.0%

Valuation Snapshot

Bullrun's latest valuation model marks CVS Health Corp as 27.9% overvalued; latest market cap is USD 132.16B; P/E is 45.5; dividend yield is 2.6%.

About CVS Health Corp

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services.

Frequently asked questions

Is CVS Health Corp overvalued or undervalued?

Bullrun's valuation model currently marks CVS Health Corp as 27.9% overvalued.

What is CVS Health Corp's market cap?

CVS Health Corp's market capitalization is USD 132.16B.

What is CVS Health Corp's P/E ratio?

CVS Health Corp's price-to-earnings (P/E) ratio is 45.5.

Does CVS Health Corp pay a dividend?

CVS Health Corp has a dividend yield of 2.6%.

What does CVS Health Corp do?

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans;